Skip to main content
logo
Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
28.09
+0.86 (3.16%)
At close: May 27, 2026

Shukra Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Shukra Pharmaceuticals had annual revenue of 567.27M INR with 74.08% growth. Shukra Pharmaceuticals had revenue of 63.24M in the quarter ending March 31, 2026, a decrease of -39.93%.

Revenue
567.27M
Revenue Growth
+74.08%
P/S Ratio
21.10
Revenue / Employee
4.93M
Employees
115
Market Cap
11.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026567.27M241.40M74.08%
Mar 31, 2025325.87M-419.86M-56.30%
Mar 31, 2024745.73M150.80M25.35%
Mar 31, 2023594.93M390.07M190.41%
Mar 31, 2022204.86M92.90M82.97%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
TTK Healthcare8.30B
Sudarshan Pharma Industries7.12B
Venus Remedies7.03B
Kopran6.81B
Wanbury6.58B
Lincoln Pharmaceuticals6.52B
Fredun Pharmaceuticals5.91B
Fermenta Biotech5.44B
Revenue Rankings

Shukra Pharmaceuticals News

More News